Ireland· IE-PA-PA2315/110/001
Montelukast Paediatric 4mg Chewable Tablets
A montelukast product containing montelukast, registered in Ireland by Accord Healthcare Ireland Ltd.. The same ATC class is registered in 19 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Montelukast is registered in 19 of 19 countries.
Countries holding a registration under ATC R03DC03 (montelukast), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 11 of them publish a price we can compare per daily dose
Montelukast · ATC R03DC03
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of montelukast costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.59 in Italy to $1.71 in Spain — a ×2.9 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Montelukast · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- ES Spain$1.71
- CH Switzerland$1.41
- FR France$0.71
- IT Italy$0.59
The record
At a glance
HPRA (Ireland)- Active substance
- Montelukast
- Manufacturer
- Accord Healthcare Ireland Ltd.
- Country
- Ireland (IE)
- ATC code
- R03DC03
- ATC class
- Montelukast
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA2315/110/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
565 interactions on record for montelukast.
Graded by severity as the source publishes them — 101 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Montelukast · interactions on record
565 records
- 101 moderate
- 464 info
Most severe, free to view
- MiconazoleA07AC01moderate
- TroglitazoneA10BG01moderate
- NateglinideA10BX03moderate
- NitisinoneA16AX04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/da2cc7df-00fc-456b-99af-d5b7cbb6e708 GET /v1/drugs/da2cc7df-00fc-456b-99af-d5b7cbb6e708?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Chewable tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"R03DC",
"R03DC03"
],
"strength": null,
"pa_number": "PA2315/110/001",
"substances": [
"Montelukast"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "03/06/2011",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": "IC0023-008-007"
}See everything about montelukast.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.